Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Dilek Guvenc, Sinem Inal, Nilufer Kuruca, Sedat Gokmen & Tolga Guvenc. (2022) Synthetic pyrethroids common metabolite 3-phenoxybenzoic acid induces caspase-3 and Bcl-2 mediated apoptosis in human hepatocyte cells. Drug and Chemical Toxicology 45:5, pages 1971-1977.
Read now
Read now
Huajing Yang, Hui Jing, Xue Han, Haoyan Tan & Wen Cheng. (2021) Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma. Drug Design, Development and Therapy 15, pages 531-542.
Read now
Read now
Dongna Su. (2021) The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma. Bioengineered 12:2, pages 11124-11135.
Read now
Read now
Binquan Wu, Amin Li, Yinci Zhang, Xueke Liu, Shuping Zhou, Huaiyong Gan, Shiyu Cai, Yong Liang & Xiaolong Tang. (2020) Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K/mTOR inhibitor BEZ235 and sorafenib in nanoparticles. Expert Opinion on Drug Delivery 17:4, pages 573-587.
Read now
Read now
Mahmoud MA Elsayed, Mahmoud E Mostafa, Eman Alaaeldin, Hatem AA Sarhan, Montaser ShA Shaykoon, Shady Allam, Ahmed RH Ahmed & Bakheet EM Elsadek. (2019) Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma. International Journal of Nanomedicine 14, pages 8445-8467.
Read now
Read now
Jiahe Hu, Jialan Shi, Yingqian Gao, Wei Yang, Ping Liu, Qinghao Liu, Fei He, Chunxu Wang, Tao Li, Rui Xie, Jiuxin Zhu & Piaoping Yang. (2019) 808 nm Near-Infrared Light-Excited UCNPs@mSiO2-Ce6-GPC3 Nanocomposites For Photodynamic Therapy In Liver Cancer. International Journal of Nanomedicine 14, pages 10009-10021.
Read now
Read now
Articles from other publishers (35)
Leming Sun, Hongmei Liu, Yanqi Ye, Yang Lei, Rehmat Islam, Sumin Tan, Rongsheng Tong, Yang-Bao Miao & Lulu Cai. (2023) Smart nanoparticles for cancer therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Mamta Kumari, Amitabha Acharya & Praveen Thaggikuppe Krishnamurthy. (2023) Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics. Beilstein Journal of Nanotechnology 14, pages 912-926.
Crossref
Crossref
Abdullah S. Alshetaili, Raisuddin Ali, Wajhul Qamar, Salman Almohizea & Md. Khalid Anwer. (2023) Preparation, optimization, and characterization of chrysin-loaded TPGS-b-PCL micelles and assessment of their cytotoxic potential in human liver cancer (Hep G2) cell lines. International Journal of Biological Macromolecules 246, pages 125679.
Crossref
Crossref
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, Ali Mohammed Obayes, Zafar Aminov, Fahad Alsaikhan, Andrés Alexis Ramírez-Coronel, Pushpamala Ramaiah, Nahla A. Tayyib & Xuanming Luo. (2023) Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches. Environmental Research 228, pages 115767.
Crossref
Crossref
Anita Bakrania, Jeffrey To, Gang Zheng & Mamatha Bhat. (2023) Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine. Gastro Hep Advances 2:7, pages 948-963.
Crossref
Crossref
Ana Camila Marques, Paulo Cardoso da Costa, Sérgia Velho & Maria Helena Amaral. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
43
.
Zhiqiang Han, Bo Song, Jiyuan Yang, Bo Wang, Zhongqiang Ma, Long Yu, Yuanhao Li, Haijin Xu & Mingqiang Qiao. (2022) Curcumin-Encapsulated Fusion Protein-Based Nanocarrier Demonstrated Highly Efficient Epidermal Growth Factor Receptor-Targeted Treatment of Colorectal Cancer. Journal of Agricultural and Food Chemistry 70:49, pages 15464-15473.
Crossref
Crossref
Sisi Yang, Chengwei Cai, Huanqiu Wang, Xueqing Ma, Anwen Shao, Jifang Sheng & Chengbo Yu. (2022) Drug delivery strategy in hepatocellular carcinoma therapy. Cell Communication and Signaling 20:1.
Crossref
Crossref
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor & Giuseppe Toffoli. (2022) Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. International Journal of Molecular Sciences 23:17, pages 10038.
Crossref
Crossref
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk & Piero Portincasa. (2022) Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 14:6, pages 1493.
Crossref
Crossref
AASTHA MITTAL, NEELAM MAHALA, KOWTHAVARAPU VENKATA KRISHNA, UMA S. DUBEY & SUNIL KUMAR DUBEY. (2022) Calcium chloride linked camel milk derived casein nanoparticles for the delivery of sorafenib in hepatocarcinoma cells. BIOCELL 46:1, pages 127-136.
Crossref
Crossref
Anita Bakrania, Gang Zheng & Mamatha Bhat. (2021) Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment. Pharmaceutics 14:1, pages 41.
Crossref
Crossref
Keenan J. Mintz & Roger M. Leblanc. (2021) The use of nanotechnology to combat liver cancer: Progress and perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188621.
Crossref
Crossref
Teng Hou, Tianqi Wang, Weiwei Mu, Rui Yang, Shuang Liang, Zipeng Zhang, Shunli Fu, Tong Gao, Yongjun Liu & Na Zhang. (2020) Nanoparticle-Loaded Polarized-Macrophages for Enhanced Tumor Targeting and Cell-Chemotherapy. Nano-Micro Letters 13:1.
Crossref
Crossref
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang & Hong-Wei Cheng. (2021) Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 13:10, pages 1213-1228.
Crossref
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Crossref
Eleonora Russo, Andrea Spallarossa, Bruno Tasso, Carla Villa & Chiara Brullo. (2021) Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. International Journal of Molecular Sciences 22:12, pages 6538.
Crossref
Crossref
Theeraphong Pho-iam, Primana Punnakitikashem, Chayapol Somboonyosdech, Sirinapa Sripinitchai, Patarabutr Masaratana, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Chamaiphorn Wongwan, Kytai T. Nguyen & Chatchawan Srisawat. (2021) PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line. Biochemical and Biophysical Research Communications 553, pages 191-197.
Crossref
Crossref
Fangmin Chen, Yifan Fang, Xiang Chen, Rui Deng, Yongjie Zhang & Jingwei Shao. (2021) Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy. Asian Journal of Pharmaceutical Sciences 16:3, pages 318-336.
Crossref
Crossref
Shuping Zhou, Yongfang Ma, Xueke Liu, Pan Yu, Ning Huang, Li Song, Ruyue Xu, Zhen Huo, Tao Zhu & Xiaolong Tang. (2021) Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells. Journal of Biomedical Nanotechnology 17:4, pages 677-690.
Crossref
Crossref
Xin Zhao, Jiaxuan Zou, Ziwei Wang, Ge Li & Yi Lei. (2021) Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer. BioMed Research International 2021, pages 1-12.
Crossref
Crossref
Nora Bloise, Mohammad Okkeh, Elisa Restivo, Cristina Della Pina & Livia Visai. (2021) Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis. Nanomaterials 11:2, pages 289.
Crossref
Crossref
Meenu Chopra, Agustin Sgro, Marck Norret, Pilar Blancafort, K. Swaminathan Iyer & Cameron W. Evans. (2020) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination. ACS Applied Bio Materials 4:1, pages 1023-1029.
Crossref
Crossref
Xiaolong Tang, Amin Li, Chunmei Xie, Yinci Zhang, Xueke Liu, Yinghai Xie, Binquan Wu, Shuping Zhou, Xudong Huang, Yongfang Ma, Weiya Cao, Ruyue Xu, Jing Shen, Zhen Huo, Shuyu Cai, Yong Liang & Dong Ma. (2020) RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway. Nanoscale Research Letters 15:1.
Crossref
Crossref
Jing Shen, Wenpeng Cai, Yongfang Ma, Ruyue Xu, Zhen Huo, Li Song, Xinyin Qiu, Yinci Zhang, Amin Li, Weiya Cao, Shuping Zhou & Xiaolong Tang. (2020) hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway. Nanoscale Research Letters 15:1.
Crossref
Crossref
Baoshan LiYi JiangJingxin ChuQian Zhou. (2020) Drug-Target Interaction Network Analysis of Gene-Phenotype Connectivity Maintained by Genistein. Journal of Computational Biology 27:12, pages 1678-1687.
Crossref
Crossref
Cheng Zhou, Yifeng Xia, Yaohua Wei, Liang Cheng, Jingjing Wei, Beibei Guo, Fenghua Meng, Shoupeng Cao, Jan C.M. van Hest & Zhiyuan Zhong. (2020) GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma. Acta Biomaterialia 113, pages 512-521.
Crossref
Crossref
Mehmet Ozcan, Ozlem Altay, Simon Lam, Hasan Turkez, Yasemin Aksoy, Jens Nielsen, Mathias Uhlen, Jan Boren & Adil Mardinoglu. (2020) Improvement in the Current Therapies for Hepatocellular Carcinoma Using a Systems Medicine Approach. Advanced Biosystems 4:6, pages 2000030.
Crossref
Crossref
A.C. Marques, P.J. Costa, S. Velho & M.H. Amaral. (2020) Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. Journal of Controlled Release 320, pages 180-200.
Crossref
Crossref
Lorena Baboci, Sara Capolla, Federica Di Cintio, Federico Colombo, Prisca Mauro, Michele Dal Bo, Monica Argenziano, Roberta Cavalli, Giuseppe Toffoli & Paolo Macor. (2020) The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. Journal of Oncology 2020, pages 1-15.
Crossref
Crossref
Yingwen Li, Jingjing Wei, Yaohua Wei, Liang Cheng, Beibei Guo, Fenghua Meng, Feng Li & Zhiyuan Zhong. (2019) Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma. Biomacromolecules 21:2, pages 716-724.
Crossref
Crossref
Shuo Feng, Juan Zhou, Zhao Li, Henry D. Appelman, Lili Zhao, Jiye Zhu & Thomas D. Wang. (2019) Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma. Colloids and Surfaces B: Biointerfaces 184, pages 110498.
Crossref
Crossref
Lakshmi Tunki, Hitesh Kulhari, Lakshma Nayak Vadithe, Madhusudana Kuncha, Suresh Bhargava, Deep Pooja & Ramakrishna Sistla. (2019) Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment. European Journal of Pharmaceutical Sciences 137, pages 104978.
Crossref
Crossref
Satish Shilpi. (2018) Drug targeting strategies for liver cancer and other liver diseases. MOJ Drug Design Development & Therapy 2:4.
Crossref
Crossref